• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纵向血清素能和多巴胺能结合:对帕金森病进展和左旋多巴异动症的影响。

Longitudinal Serotonergic and Dopaminergic Binding: Impact on Parkinson's Disease Progression and Levodopa Dyskinesia.

作者信息

Jeong Eun Hye, Lee Jae Yong, Song Yoo Sung

机构信息

Department of Neurology, Bundang Jesaeng General Hospital, Seongnam-si, Republic of Korea.

Department of Nuclear Medicine, Seoul National University Bundang Hospital, Seongnam-si, Republic of Korea.

出版信息

J Neuroimaging. 2025 Jan-Feb;35(1):e70014. doi: 10.1111/jon.70014.

DOI:10.1111/jon.70014
PMID:39800858
Abstract

BACKGROUND AND PURPOSE

We investigated the relationship between serotonergic and dopaminergic specific binding transporter ratios (SBRs) over 4 years in Parkinson's disease (PD) patients. We assessed serotonergic innervation's potential compensatory role for dopaminergic denervation, association with PD symptoms, and involvement in the development of levodopa-induced dyskinesia (LID).

METHODS

SBRs of the midbrain and striatum were evaluated from [I-123] N-ω-fluoropropyl-2β-carbomethoxy-3β-(4-iodophenyl)nortropane SPECT images at baseline and after 4 years. Correlations between SBRs and PD symptoms were analyzed, alongside interval changes.

RESULTS

Study included 177 PD patients (110 males, 67 females; mean age 61.0 ± 9.0 years). Significant worsening was observed in Hoehn and Yahr staging and Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Part II and III scores over 4 years (p < 0.05, p < 0.001, and p < 0.001, respectively). SBRs of the caudate, putamen, and midbrain declined significantly (p < 0.001). Midbrain and striatal SBRs correlated significantly at both baseline and 4-year follow-up (p < 0.0001). Striatal SBRs correlated significantly with MDS-UPDRS II and III scores at both time points, while midbrain SBRs correlated with changes in MDS-UPDRS III scores over the 4 years (p < 0.01). Putamen and midbrain SBRs at 4 years were significantly lower in patients who developed LID compared to those who did not (p < 0.05).

CONCLUSION

The study demonstrates correlations between midbrain and putamen SBRs and MDS-UPDRS scores over 4 years in PD patients. Midbrain serotonin dysfunction may contribute to the development of LID.

摘要

背景与目的

我们研究了帕金森病(PD)患者4年期间血清素能和多巴胺能特异性结合转运体比率(SBRs)之间的关系。我们评估了血清素能神经支配对多巴胺能去神经支配的潜在代偿作用、与PD症状的关联以及在左旋多巴诱导的异动症(LID)发生中的作用。

方法

在基线和4年后,从[I-123]N-ω-氟丙基-2β-甲氧基羰基-3β-(4-碘苯基)降冰片烷SPECT图像评估中脑和纹状体的SBRs。分析SBRs与PD症状之间的相关性以及间隔变化。

结果

研究纳入177例PD患者(男性110例,女性67例;平均年龄61.0±9.0岁)。4年期间,Hoehn和Yahr分期以及运动障碍协会统一帕金森病评定量表(MDS-UPDRS)第二部分和第三部分评分显著恶化(分别为p<0.05、p<0.001和p<0.001)。尾状核、壳核和中脑的SBRs显著下降(p<0.001)。中脑和纹状体的SBRs在基线和4年随访时均显著相关(p<0.0001)。纹状体SBRs在两个时间点均与MDS-UPDRS II和III评分显著相关,而中脑SBRs与4年期间MDS-UPDRS III评分的变化相关(p<0.01)。与未发生LID的患者相比,发生LID的患者4年时壳核和中脑的SBRs显著更低(p<0.05)。

结论

该研究证明了PD患者4年期间中脑和壳核SBRs与MDS-UPDRS评分之间的相关性。中脑血清素功能障碍可能导致LID的发生。

相似文献

1
Longitudinal Serotonergic and Dopaminergic Binding: Impact on Parkinson's Disease Progression and Levodopa Dyskinesia.纵向血清素能和多巴胺能结合:对帕金森病进展和左旋多巴异动症的影响。
J Neuroimaging. 2025 Jan-Feb;35(1):e70014. doi: 10.1111/jon.70014.
2
Serial I-123-FP-CIT SPECT Image Findings of Parkinson's Disease Patients With Levodopa-Induced Dyskinesia.左旋多巴诱发异动症的帕金森病患者的系列I-123-FP-CIT单光子发射计算机断层扫描影像结果
Front Neurol. 2018 Dec 20;9:1133. doi: 10.3389/fneur.2018.01133. eCollection 2018.
3
Serotonin transporters in the midbrain of Parkinson's disease patients: a study with 123I-beta-CIT SPECT.帕金森病患者中脑的5-羟色胺转运体:一项使用123I-β-CIT单光子发射计算机断层扫描的研究
J Nucl Med. 2003 Jun;44(6):870-6.
4
Serotonin-to-dopamine transporter ratios in Parkinson disease: Relevance for dyskinesias.帕金森病中5-羟色胺与多巴胺转运体比率:与运动障碍的相关性。
Neurology. 2016 Mar 22;86(12):1152-8. doi: 10.1212/WNL.0000000000002494. Epub 2016 Feb 26.
5
Serotonergic markers in Parkinson's disease and levodopa-induced dyskinesias.帕金森病和左旋多巴诱导运动障碍中的血清素标志物。
Mov Disord. 2015 May;30(6):796-804. doi: 10.1002/mds.26144. Epub 2015 Feb 4.
6
Chronic exposure to dopamine agonists affects the integrity of striatal D receptors in Parkinson's patients.慢性暴露于多巴胺激动剂会影响帕金森病患者纹状体 D 受体的完整性。
Neuroimage Clin. 2017 Aug 24;16:455-460. doi: 10.1016/j.nicl.2017.08.013. eCollection 2017.
7
Presynaptic dopamine depletion predicts levodopa-induced dyskinesia in de novo Parkinson disease.纹状体多巴胺能神经元缺失预测初发帕金森病患者左旋多巴诱导的运动并发症。
Neurology. 2014 May 6;82(18):1597-604. doi: 10.1212/WNL.0000000000000385. Epub 2014 Apr 9.
8
Profile of levodopa-induced dyskinesia in patients of Parkinson's disease: a record based study.帕金森病患者左旋多巴诱导的异动症概况:一项基于记录的研究。
Neurol Res. 2014 Sep;36(9):841-6. doi: 10.1179/1743132814Y.0000000339. Epub 2014 Mar 7.
9
Does Late Levodopa Administration Delay the Development of Dyskinesia in Patients with De Novo Parkinson's Disease?左旋多巴晚期给药是否会延迟新发帕金森病患者运动障碍的发展?
CNS Drugs. 2018 Oct;32(10):971-979. doi: 10.1007/s40263-018-0549-x.
10
Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias.左旋多巴引起的突触多巴胺水平变化随帕金森病进展而增加:对运动障碍的影响。
Brain. 2004 Dec;127(Pt 12):2747-54. doi: 10.1093/brain/awh290. Epub 2004 Aug 25.

引用本文的文献

1
Multiparametric quantitative MRI uncovers putamen microstructural changes in Parkinson's disease.多参数定量磁共振成像揭示帕金森病壳核的微观结构变化。
NPJ Parkinsons Dis. 2025 Jul 3;11(1):197. doi: 10.1038/s41531-025-01020-0.